Canada markets close in 5 hours 31 minutes

NervGen Pharma Corp. (NGEN.V)

TSXV - TSXV Real Time Price. Currency in CAD
Add to watchlist
2.4600-0.0200 (-0.81%)
As of 10:12AM EST. Market open.
Currency in CAD

Valuation Measures4

Market Cap (intraday) 133.80M
Enterprise Value 125.55M
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)N/A
Price/Book (mrq)16.13
Enterprise Value/Revenue N/A
Enterprise Value/EBITDA -10.58

Trading Information

Stock Price History

Beta (5Y Monthly) 1.92
52-Week Change 3-0.40%
S&P500 52-Week Change 314.85%
52 Week High 33.3300
52 Week Low 31.2600
50-Day Moving Average 32.7150
200-Day Moving Average 32.1397

Share Statistics

Avg Vol (3 month) 371.19k
Avg Vol (10 day) 343.71k
Shares Outstanding 546.14M
Implied Shares Outstanding 6N/A
Float 840.58M
% Held by Insiders 19.88%
% Held by Institutions 10.10%
Shares Short (Jan. 13, 2022) 428.85k
Short Ratio (Jan. 13, 2022) 40.82
Short % of Float (Jan. 13, 2022) 4N/A
Short % of Shares Outstanding (Jan. 13, 2022) 40.06%
Shares Short (prior month Dec. 14, 2021) 411.25k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec. 30, 2020
Most Recent Quarter (mrq)Sep. 29, 2021

Profitability

Profit Margin 0.00%
Operating Margin (ttm)0.00%

Management Effectiveness

Return on Assets (ttm)-83.35%
Return on Equity (ttm)-144.37%

Income Statement

Revenue (ttm)N/A
Revenue Per Share (ttm)N/A
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)N/A
EBITDA -13.05M
Net Income Avi to Common (ttm)-13.15M
Diluted EPS (ttm)-0.3540
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)8.25M
Total Cash Per Share (mrq)0.18
Total Debt (mrq)N/A
Total Debt/Equity (mrq)N/A
Current Ratio (mrq)8.19
Book Value Per Share (mrq)0.20

Cash Flow Statement

Operating Cash Flow (ttm)-7.36M
Levered Free Cash Flow (ttm)-2.49M